drugset / Trial / NCT00005788
Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Treatment
Summary
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill lymphoma cells. PURPOSE: Phase II trial to study the effectiveness of interleukin-2 in treating patients who have mycosis fungoides or Sezary syndrome.
Timeline
- Start
- 1997-04
- Primary completion
- 2002-01
- Completion
- 2002-01
Outcome
Outcome not reported
Stopped (Enrollment): “Low/inadequate rate of accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |